JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation inCD8+T Cells in Renal Cell Carcinoma Patients

Improving the efficacy of cancer immunotherapy

(2009) J. Copier et al.   EUROPEAN JOURNAL OF CANCER

Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients

(2009) Margherita Gigante et al.   JOURNAL OF IMMUNOTHERAPY

Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFN  in Patients with Good Prognosis Metastatic Renal Cancer

(2008) S. Negrier et al.   CLINICAL CANCER RESEARCH

Immunotherapy for renal cell cancer in the era of targeted therapy

(2008) Chris Coppin   Expert Review of Anticancer Therapy

STAT6 signalling is important in CD8+T-cell activation and defence againstToxoplasma gondiiinfection in the brain

(2008) Donghao Jin et al.   IMMUNOLOGY

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

(2008) Carolina Berger et al.   JOURNAL OF CLINICAL INVESTIGATION

Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine

(2008) M. Gigante et al.   MOLECULAR IMMUNOLOGY